No products in the cart.
Elemene Injection
$1.00
Elemene Injection is a traditional Chinese medicine–derived liposomal terpene mixture (elemene) approved in China (NMPA No. H20110114; Product Code 86909563000017). Supplied as a 10mL liposomal solution per vial (0.2g elemene), 5 vials per box. Intended strictly for laboratory and preclinical research purposes Please consult the staff for other purposes.
Description
Elemene Injection Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Elemene Injection |
| Concentration | 0.2g elemene per 10mL vial |
| Dosage Form | Liposomal injection (vial) |
| Approval No. | China NMPA H20110114 |
| Product Code | 86909563000017 |
| Manufacturer | CSPC Boda (Dalian) Pharmaceutical Co., Ltd. |
| Packaging | 5 vials × 10mL per box |
| Intended Use | Laboratory research use only — Not for human or veterinary use |
Elemene Injection Background & Mechanism
Elemene, derived from Curcuma wenyujin, is a lipophilic terpene mixture recognized for its broad-spectrum anti?tumor activity, low toxicity, and ability to reverse resistance, inhibit metastasis, and enhance immunity It induces apoptosis, cell cycle arrest, and synergizes with chemotherapy/radiotherapy agents .
Research & Clinical Evidence
Broad efficacy in pelvic cancers: Elemene plus chemotherapy showed improved Objective Response Rate (ORR) and disease control tiprpress.com+2e.dxy.cn+2zh.wikipedia.org+2.
Malignant pleural effusion (MPE): Intrathoracic elemene improved tumor control but had limited QOL benefits; safety remains a concern .
Bone metastasis pain: Intravenous/pleural elemene notably reduced cancer-related pain with mild side effects.
AiLiNeng Research Applications
Apoptosis and cell cycle studies
Combination therapy evaluations (e.g. with pemetrexed, cisplatin) zh.wikipedia.org+9tiprpress.com+9e.dxy.cn+9
Drug resistance reversal experiments
Tumor microenvironment and immunomodulation assessments
Liposome drug-delivery model development
Research Use Disclaimer
This product is intended strictly for laboratory research and development use only. Not for human or veterinary use, nor for clinical, diagnostic, or therapeutic purposes.
Additional information
| Weight | 1.1 kg |
|---|---|
| Dimensions | 26 × 24 × 26 cm |
Q1: Is this suitable for human or clinical use?
A1: No — strictly for laboratory/preclinical research use only, not approved for any clinical application.
Q2: How is it different from standard chemotherapy?
A2: Elemene is a natural terpene blend with broader antitumor effects and lower cytotoxicity. It modulates tumor biology and has immunomodulatory properties
Q3: What evidence supports its efficacy in models?
A3: It enhances chemo regimens (e.g., pemetrexed + nedaplatin) with higher ORR (~76% vs 56%) and greater immune response
Q4: What are the side effects?
A4: Generally well-tolerated in clinical use; mild fever, phlebitis, and rare local reactions noted .
Q5: How should it be stored & handled?
A5: Store vials refrigerated when unused. Use aseptic technique and lab PPE—follow biosafety protocols when handling liposomal injections.
Related products
Fulvestrant Faslodex
Fluvestrant (250mg/5ml) injectable solution, 2-vial set by EVER?Pharma Jena GmbH, Germany. A potent selective estrogen receptor degrader (SERD) used in advanced breast cancer research. $2.00Elranatamab Injection
Elranatamab (ELREXFIO®) is a BCMA-CD3 bispecific antibody used in multiple myeloma research. Supplied as a 76mg/1.9mL single-dose vial, manufactured by Pfizer. Approved by FDA (Aug 2023) and EMA (Dec 2023). Ideal for oncology, immunotherapy, and Tcell engager studies.
$1.00Doxorubicin Liposome Injection
is a liposomal formulation of doxorubicin, offering enhanced circulation time and reduced cardiotoxicity compared to the traditional form. Supplied as 20mg per 10mL vial, it is strictly for laboratory research use only—not for clinical or human application. Please consult the staff for other purposes. $2.00Rilertinib Mesylate Tablets (Sanrisso) – 100mg
Rilertinib mesylate (Sanrisso), developed by Nanjing Sanhome Pharmaceutical Co., Ltd., is a third-generation EGFR-TKI approved by China's NMPA (Approval No. H20240020; Drug Code: 86901583000930). Each bottle contains 20 tablets of 100mg each. Strictly for laboratory research use only—not for clinical or human use. $1.00
Reviews
There are no reviews yet.